| A-674563 |
552325-73-2 |
A-674563 is a potent serine/threonine kinase Akt (PKB) inhibitor.... |
| A-769662 |
844499-71-4 |
.... |
| A66 |
1166227-08-2 |
.... |
| A66 |
1166227-08-2 |
.... |
| A66 |
1166227-08-2 |
.... |
| A66 |
1166227-08-2 |
.... |
| ADL5859 HCl |
850173-95-4 |
.... |
| ADL5859 HCl |
850173-95-4 |
.... |
| AKT Kinase Inhibitor |
842148-40-7 |
.... |
| AMG517 |
659730-32-2 |
.... |
| AP-23573 (MK-8669) |
572924-54-0 |
AP23573 is a novel mammalian target of rapmycin (mTOR) inhibitor.... |
| AP-23573 (MK-8669) |
572924-54-0 |
AP23573 is a novel mammalian target of rapmycin (mTOR) inhibitor.... |
| AP-23573 (MK-8669) |
572924-54-0 |
AP23573 is a novel mammalian target of rapmycin (mTOR) inhibitor.... |
| AP-23573 (MK-8669) |
572924-54-0 |
AP23573 is a novel mammalian target of rapmycin (mTOR) inhibitor.... |
| AS252424 |
900515-16-4 |
.... |
| AS252424 |
900515-16-4 |
.... |
| AS252424 |
900515-16-4 |
.... |
| AT7867 |
857531-00-1 |
AT7867 is a potent and oral inhibitor of AKT and p70 S6 kinase.... |
| AT7867 |
857531-00-1 |
AT7867 is a potent and oral inhibitor of AKT and p70 S6 kinase.... |
| AT7867 |
857531-00-1 |
AT7867 is a potent and oral inhibitor of AKT and p70 S6 kinase.... |
| AZD-5363 |
1143532-39-1 |
AZD-5363 is a potent and selective inhibitor of AKT.... |
| AZD-5363 |
1143532-39-1 |
AZD-5363 is a potent and selective inhibitor of AKT.... |
| AZD1080 |
612487-72-6 |
AZD1080 is a potent and selective GSK3 inhibitor that demonstrates peripheral target engagement in Phase 1 clinical studies.... |
| AZD1080 |
612487-72-6 |
AZD1080 is a potent and selective GSK3 inhibitor that demonstrates peripheral target engagement in Phase 1 clinical studies.... |
| AZD2014 |
1009298-59-2 |
AZD2014 is a mammalian target of rapamycin (mTOR) C1/C2 dual inhibitor.... |
| AZD6482 |
1173900-33-8 |
KIN-193 is a potent and selective p110β inhibitor.... |
| AZD6482 |
1173900-33-8 |
KIN-193 is a potent and selective p110β inhibitor.... |
| AZD6482 |
1173900-33-8 |
KIN-193 is a potent and selective p110β inhibitor.... |
| AZD8055 |
1009298-09-2 |
AZD8055 is a novel ATP-competitive inhibitor of mTOR kinase activity.... |
| AZD8055 |
1009298-09-2 |
AZD8055 is a novel ATP-competitive inhibitor of mTOR kinase activity.... |
| BAN ORL 24 HCl |
475150-69-7 |
.... |
| BAY 80-6946 |
1032568-63-0 |
BAY 80-6946 is a potent, selective and reversible PI3K inhibitor for PI3Kα/β with IC50 of 0.469 nM/3.72 nM.... |
| BAY 80-6946 |
1032568-63-0 |
BAY 80-6946 is a potent, selective and reversible PI3K inhibitor for PI3Kα/β with IC50 of 0.469 nM/3.72 nM.... |
| BAY 80-6946 |
1032568-63-0 |
BAY 80-6946 is a potent, selective and reversible PI3K inhibitor for PI3Kα/β with IC50 of 0.469 nM/3.72 nM.... |
| BKM120 |
944396-07-0 |
BKM120 is an available pan-Class I PI3-kinase inhibitor.... |
| BKM120 |
944396-07-0 |
BKM120 is an available pan-Class I PI3-kinase inhibitor.... |
| BKM120 |
944396-07-0 |
BKM120 is an available pan-Class I PI3-kinase inhibitor.... |
| BMS790052 |
1009119-65-6 |
.... |
| BX-912 |
702674-56-4 |
BX-912 is a selective and potent PDK1 inhibitor with an IC50 of 12 nM.... |
| BX795 |
702675-74-9 |
BX795 is a potent and selective dual inhibitor of TBK1/PDK1 with IC50s of 2 nM/6 nM respectively [1].... |
| BX795 |
702675-74-9 |
BX795 is a potent and selective dual inhibitor of TBK1/PDK1 with IC50s of 2 nM/6 nM respectively [1].... |
| BX795 |
702675-74-9 |
BX795 is a potent and selective dual inhibitor of TBK1/PDK1 with IC50s of 2 nM/6 nM respectively [1].... |
| BX795 |
702675-74-9 |
BX795 is a potent and selective dual inhibitor of TBK1/PDK1 with IC50s of 2 nM/6 nM respectively [1].... |
| BYL-719 |
1217486-61-7 |
BYL-719 is a potent and selective inhibitor of PI3Kα.... |
| BYL-719 |
1217486-61-7 |
BYL-719 is a potent and selective inhibitor of PI3Kα.... |
| BYL-719 |
1217486-61-7 |
BYL-719 is a potent and selective inhibitor of PI3Kα.... |
| BYL-719 |
1217486-61-7 |
BYL-719 is a potent and selective inhibitor of PI3Kα.... |
| CAL-101 |
870281-82-6 |
CAL-101 is a potent and selective inhibitor of p110d with an IC50 of 2.5 nM.... |
| CAL-101 |
870281-82-6 |
CAL-101 is a potent and selective inhibitor of p110d with an IC50 of 2.5 nM.... |
| CAL-101 |
870281-82-6 |
CAL-101 is a potent and selective inhibitor of p110d with an IC50 of 2.5 nM.... |
| CAY10505 |
1218777-13-9 |
.... |
| CAY10505 |
1218777-13-9 |
.... |
| CAY10505 |
1218777-13-9 |
.... |
| CAY10505 |
1218777-13-9 |
.... |
| CCT128930 |
885499-61-6 |
.... |
| CH5132799 |
1007207-67-1 |
CH5132799 potently and selectively inhibits PI3Kα and mTOR with IC50 values of 14 nM and 1.6 µM, respectively.... |
| CH5132799 |
1007207-67-1 |
CH5132799 potently and selectively inhibits PI3Kα and mTOR with IC50 values of 14 nM and 1.6 µM, respectively.... |
| CH5132799 |
1007207-67-1 |
CH5132799 potently and selectively inhibits PI3Kα and mTOR with IC50 values of 14 nM and 1.6 µM, respectively.... |
| CH5132799 |
1007207-67-1 |
CH5132799 potently and selectively inhibits PI3Kα and mTOR with IC50 values of 14 nM and 1.6 µM, respectively.... |
| CHIR-98014 |
252935-94-7 |
CHIR-98014 is a potent inhibitor of glycogen synthase kinase-3 (GSK-3).... |
| CT99021 |
252917-06-9 |
CT99021 is a GSK-3 inhibitor with IC50 of 10 and 6.7 nM for GSK-3α and GSK-3β, respectively.... |
| CT99021 |
252917-06-9 |
CT99021 is a GSK-3 inhibitor with IC50 of 10 and 6.7 nM for GSK-3α and GSK-3β, respectively.... |
| CT99021 |
252917-06-9 |
CT99021 is a GSK-3 inhibitor with IC50 of 10 and 6.7 nM for GSK-3α and GSK-3β, respectively.... |
| CT99021 |
252917-06-9 |
CT99021 is a GSK-3 inhibitor with IC50 of 10 and 6.7 nM for GSK-3α and GSK-3β, respectively.... |
| CUDC-907 |
1339928-25-4 |
CUDC-907 is a potent inhibitor of both HDAC and PI3K.... |
| CUDC-907 |
1339928-25-4 |
CUDC-907 is a potent inhibitor of both HDAC and PI3K.... |
| CUDC-907 |
1339928-25-4 |
CUDC-907 is a potent inhibitor of both HDAC and PI3K.... |
| CUDC-907 |
1339928-25-4 |
CUDC-907 is a potent inhibitor of both HDAC and PI3K.... |
| CZC24832 |
1159824-67-5 |
CZC24832 is a highly selective and potent ATP-competitive PI3Kγ inhibitor.... |
| CZC24832 |
1159824-67-5 |
CZC24832 is a highly selective and potent ATP-competitive PI3Kγ inhibitor.... |
| DBeq |
177355-84-9 |
.... |
| ETP-46464 |
1345675-02-6 |
ETP-46464 is a potent inhibitor of mTOR, ATR, DNA-PK, PI 3-KΑ and ATM.... |
| Everolimus |
159351-69-6 |
.... |
| Everolimus |
159351-69-6 |
.... |
| Everolimus |
159351-69-6 |
.... |
| Everolimus (Rad001) |
159351-69-6 |
Everolimus is an inhibitor of mammalian target of rapamycin (mTOR).... |
| Everolimus (Rad001) |
159351-69-6 |
Everolimus is an inhibitor of mammalian target of rapamycin (mTOR).... |
| Everolimus (Rad001) |
159351-69-6 |
Everolimus is an inhibitor of mammalian target of rapamycin (mTOR).... |
| GDC-0941 |
957054-30-7 |
GDC-0941 is a novel small-molecule inhibitor of PI3Kα, PI3Kβ, PI3Kδ and PI3Kγ with IC50 of 3, 33, 3 and 75 nM, respectively.... |
| GDC-0941 |
957054-30-7 |
GDC-0941 is a novel small-molecule inhibitor of PI3Kα, PI3Kβ, PI3Kδ and PI3Kγ with IC50 of 3, 33, 3 and 75 nM, respectively.... |
| GDC-0941 |
957054-30-7 |
GDC-0941 is a novel small-molecule inhibitor of PI3Kα, PI3Kβ, PI3Kδ and PI3Kγ with IC50 of 3, 33, 3 and 75 nM, respectively.... |
| GDC-0941 |
957054-30-7 |
GDC-0941 is a novel small-molecule inhibitor of PI3Kα, PI3Kβ, PI3Kδ and PI3Kγ with IC50 of 3, 33, 3 and 75 nM, respectively.... |
| GDC-0980 |
1032754-93-0 |
GDC-0980 is a potent, selective and oral inhibitor of class I PI3K and mTOR kinase.... |
| GDC0068 |
1001264-89-6 |
GDC0068 is a selective ATP-competitive Akt inhibitor.... |
| GDC0068 |
1001264-89-6 |
GDC0068 is a selective ATP-competitive Akt inhibitor.... |
| GDC0068 |
1001264-89-6 |
GDC0068 is a selective ATP-competitive Akt inhibitor.... |
| GDC0068 |
1001264-89-6 |
GDC0068 is a selective ATP-competitive Akt inhibitor.... |
| GDC0941 |
957054-33-0 |
.... |
| GDC0941 |
957054-33-0 |
.... |
| GDC0941 |
957054-33-0 |
.... |
| GDC0941 |
957054-33-0 |
.... |
| GSK-2636771 |
1372540-25-4 |
GSK-2636771 is a PI3K p110β isoform specific inhibitor.... |
| GSK2126458 |
1086062-66-9 |
GSK2126458 is a highly potent inhibitor of PI3K and the mammalian target of rapamycin (mTOR).... |
| GSK690693 |
937174-76-0 |
GSK690693 is a novel ATP competitive, pan-AKT kinase inhibitor.... |
| GSK690693 |
937174-76-0 |
GSK690693 is a novel ATP competitive, pan-AKT kinase inhibitor.... |
| GSK690693 |
937174-76-0 |
GSK690693 is a novel ATP competitive, pan-AKT kinase inhibitor.... |
| IC-87114 |
371242-69-2 |
IC-87114 is a highly selective antagonist of PI3Kδ.... |
| IC-87114 |
371242-69-2 |
IC-87114 is a highly selective antagonist of PI3Kδ.... |
| IC-87114 |
371242-69-2 |
IC-87114 is a highly selective antagonist of PI3Kδ.... |
| Indirubin |
479-41-4 |
Indirubin is potent cyclin-dependent kinases and GSK-3M-NM-2 inhibitor with IC50 of about 75 nM and 0.19 µM, respectively [1].... |
| Indirubin |
479-41-4 |
Indirubin is potent cyclin-dependent kinases and GSK-3M-NM-2 inhibitor with IC50 of about 75 nM and 0.19 µM, respectively [1].... |
| Indirubin |
479-41-4 |
Indirubin is potent cyclin-dependent kinases and GSK-3M-NM-2 inhibitor with IC50 of about 75 nM and 0.19 µM, respectively [1].... |
| Indirubin |
479-41-4 |
Indirubin is potent cyclin-dependent kinases and GSK-3M-NM-2 inhibitor with IC50 of about 75 nM and 0.19 µM, respectively [1].... |
| Kenpaullone |
142273-20-9 |
Kenpaullone is a potent ATP-competitive GSK3-β and CDK inhibitor.... |
| KU-0063794 |
938440-64-3 |
Ku-0063794 is a specific inhibitor of the mammalian target of rapamycin (mTOR).... |
| KU-55933 |
587871-26-9 |
KU-55933 is a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase (ATM).... |
| KU-55933 |
587871-26-9 |
KU-55933 is a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase (ATM).... |
| KU-55933 |
587871-26-9 |
KU-55933 is a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase (ATM).... |
| LY294002 |
154447-36-6 |
LY294002 is a competitive, reversible inhibitor of PI3K.... |
| MK-2206 |
1032350-13-2 |
MK-2206 is a highly selective non-ATP competitive allosteric Akt inhibitor that is equally potent towards purified recombinant human Akt1 and Akt2 and approximately five fold less potent against human Akt3 (IC50= 8, 12, and 65 nM, respectively) in enzyme assays.... |
| MK-2206 |
1032350-13-2 |
MK-2206 is a highly selective non-ATP competitive allosteric Akt inhibitor that is equally potent towards purified recombinant human Akt1 and Akt2 and approximately five fold less potent against human Akt3 (IC50= 8, 12, and 65 nM, respectively) in enzyme assays.... |
| NVP-BEZ235 |
915019-65-7 |
NVP-BEZ235 is a novel dual phosphatidylinositol 3-kinase (P13K)/mammalian target of rapamycin (mTOR) inhibitor in gliomas.... |
| NVP-BEZ235 |
915019-65-7 |
NVP-BEZ235 is a novel dual phosphatidylinositol 3-kinase (P13K)/mammalian target of rapamycin (mTOR) inhibitor in gliomas.... |
| NVP-BGT226 |
1245537-68-1 |
NVP-BGT226 is a dual phosphatidylinositol 3-kinase (PI3K)/mammalian target of rapamycin (mTOR) (both mTORC1 and mTORC2) inhibitor.... |
| NVP-BGT226 |
1245537-68-1 |
NVP-BGT226 is a dual phosphatidylinositol 3-kinase (PI3K)/mammalian target of rapamycin (mTOR) (both mTORC1 and mTORC2) inhibitor.... |
| NVP-BGT226 |
1245537-68-1 |
NVP-BGT226 is a dual phosphatidylinositol 3-kinase (PI3K)/mammalian target of rapamycin (mTOR) (both mTORC1 and mTORC2) inhibitor.... |
| NVP-BGT226 |
1245537-68-1 |
NVP-BGT226 is a dual phosphatidylinositol 3-kinase (PI3K)/mammalian target of rapamycin (mTOR) (both mTORC1 and mTORC2) inhibitor.... |
| OSI-027 |
936890-98-1 |
OSI-027 is a potent dual inhibitor of mTORC1 and mTORC2 with IC50 values of 22 and 65 nM, respectively.... |
| OSI-027 |
936890-98-1 |
OSI-027 is a potent dual inhibitor of mTORC1 and mTORC2 with IC50 values of 22 and 65 nM, respectively.... |
| OSI-027 |
936890-98-1 |
OSI-027 is a potent dual inhibitor of mTORC1 and mTORC2 with IC50 values of 22 and 65 nM, respectively.... |
| OSU03012 |
742112-33-0 |
.... |
| OSU03012 |
742112-33-0 |
.... |
| OSU03012 |
742112-33-0 |
.... |
| Palomid-529 |
914913-88-5 |
Palomid-529 is a novel and potent PI3K/Akt/mTOR inhibitor.... |
| Palomid-529 |
914913-88-5 |
Palomid-529 is a novel and potent PI3K/Akt/mTOR inhibitor.... |
| Palomid-529 |
914913-88-5 |
Palomid-529 is a novel and potent PI3K/Akt/mTOR inhibitor.... |
| Palomid-529 |
914913-88-5 |
Palomid-529 is a novel and potent PI3K/Akt/mTOR inhibitor.... |
| PF-04691502 |
1013101-36-4 |
PF-04691502 is an ATP-competitive PI3K/mTOR dual inhibitor.... |
| PFK15 |
372196-77-5 |
.... |
| PFK15 |
372196-77-5 |
.... |
| PFK15 |
372196-77-5 |
.... |
| PHT-427 |
1191951-57-1 |
PHT-427 is a novel AKT/PDPK1 pleckstrin homology domain inhibitor.... |
| PHT-427 |
1191951-57-1 |
PHT-427 is a novel AKT/PDPK1 pleckstrin homology domain inhibitor.... |
| PHT-427 |
1191951-57-1 |
PHT-427 is a novel AKT/PDPK1 pleckstrin homology domain inhibitor.... |
| PI-103 |
371935-74-9 |
PI-103 is a dual inhibitor of phosphatidylinositide 3-kinase (PI3K) and mammalian target of rapamycin (mTOR).... |
| PI-103 |
371935-74-9 |
PI-103 is a dual inhibitor of phosphatidylinositide 3-kinase (PI3K) and mammalian target of rapamycin (mTOR).... |
| PI-103 |
371935-74-9 |
PI-103 is a dual inhibitor of phosphatidylinositide 3-kinase (PI3K) and mammalian target of rapamycin (mTOR).... |
| PI-103 |
371935-74-9 |
PI-103 is a dual inhibitor of phosphatidylinositide 3-kinase (PI3K) and mammalian target of rapamycin (mTOR).... |
| PI-103 |
371935-74-9 |
PI-103 is a dual inhibitor of phosphatidylinositide 3-kinase (PI3K) and mammalian target of rapamycin (mTOR).... |
| PIK-75 |
372196-67-3 |
PIK-75 is a PI3K p110α-specific inhibitor.... |
| PIK-93 |
593960-11-3 |
PIK-93 is the first potent, synthetic Phosphoinositide kinases (PIK) inhibitor.... |
| PKI-402 |
1173204-81-3 |
PKI-402 is a selective, reversible and ATP-competitive inhibitor of class I phosphatidylinositol 3-kinases (PI3K).... |
| PKI587 |
1197160-78-3 |
PKI587 is a highly potent dual PI3K/mTOR kinase inhibitor.... |
| PP242 |
1092351-67-1 |
PP242 is a mammalian target of rapamycin (mTOR) inhibitor.... |
| PP242 |
1092351-67-1 |
PP242 is a mammalian target of rapamycin (mTOR) inhibitor.... |
| PP242 |
1092351-67-1 |
PP242 is a mammalian target of rapamycin (mTOR) inhibitor.... |
| PX-866 |
502632-66-8 |
PX-866, a derivative of wortmannin, is a potent PI3 Kinase inhibitor.... |
| PX-866 |
502632-66-8 |
PX-866, a derivative of wortmannin, is a potent PI3 Kinase inhibitor.... |
| PX-866 |
502632-66-8 |
PX-866, a derivative of wortmannin, is a potent PI3 Kinase inhibitor.... |
| PX-866 |
502632-66-8 |
PX-866, a derivative of wortmannin, is a potent PI3 Kinase inhibitor.... |
| Rapamycin |
53123-88-9 |
Rapamycin forms a complex with FK506-binding protein 12 that binds and inhibits mammalian target of TOR kinase activity, leading to dephosphorylation of downstream targets of mTOR, S6K1, and 4E-BP1.... |
| Rapamycin |
53123-88-9 |
Rapamycin forms a complex with FK506-binding protein 12 that binds and inhibits mammalian target of TOR kinase activity, leading to dephosphorylation of downstream targets of mTOR, S6K1, and 4E-BP1.... |
| Rapamycin |
53123-88-9 |
Rapamycin forms a complex with FK506-binding protein 12 that binds and inhibits mammalian target of TOR kinase activity, leading to dephosphorylation of downstream targets of mTOR, S6K1, and 4E-BP1.... |
| SB 216763 |
280744-09-4 |
SB 216763 is a potent, selective, and ATP-competitive inhibitor of glycogen synthase kinase-3 (GSK-3).... |
| SB 415286 |
264218-23-7 |
SB 415286 is a potent and selective cell permeable glycogen synthase kinase 3 (GSK3) inhibitor.... |
| SB 415286 |
264218-23-7 |
SB 415286 is a potent and selective cell permeable glycogen synthase kinase 3 (GSK3) inhibitor.... |
| SCH727965 |
779353-01-4 |
.... |
| Temsirolimus |
162635-04-3 |
Temsirolimus is a specific inhibitor of mTOR used in the treatment of renal cell carcinoma.... |
| Temsirolimus |
162635-04-3 |
Temsirolimus is a specific inhibitor of mTOR used in the treatment of renal cell carcinoma.... |
| Temsirolimus |
162635-04-3 |
Temsirolimus is a specific inhibitor of mTOR used in the treatment of renal cell carcinoma.... |
| Temsirolimus |
162635-04-3 |
Temsirolimus is a specific inhibitor of mTOR used in the treatment of renal cell carcinoma.... |
| TGX-221 |
663619-89-4 |
TGX-221 is a potent and selective phosphoinositide 3-kinase (PI3K) p110β inhibitor with an IC50 of 8.5 nM.... |
| TGX-221 |
663619-89-4 |
TGX-221 is a potent and selective phosphoinositide 3-kinase (PI3K) p110β inhibitor with an IC50 of 8.5 nM.... |
| TGX-221 |
663619-89-4 |
TGX-221 is a potent and selective phosphoinositide 3-kinase (PI3K) p110β inhibitor with an IC50 of 8.5 nM.... |
| Torin2 |
1223001-51-1 |
Torin 2 is a potent, selective and orally available mTOR inhibitor.... |
| Torin2 |
1223001-51-1 |
Torin 2 is a potent, selective and orally available mTOR inhibitor.... |
| Torin2 |
1223001-51-1 |
Torin 2 is a potent, selective and orally available mTOR inhibitor.... |
| Torin2 |
1223001-51-1 |
Torin 2 is a potent, selective and orally available mTOR inhibitor.... |
| TPCA1 |
507475-17-4 |
.... |
| Triciribine |
35943-35-2 |
Triciribine is a potent Akt inhibitor with IC50 of 130 nM.... |
| Triciribine |
35943-35-2 |
Triciribine is a potent Akt inhibitor with IC50 of 130 nM.... |
| Triciribine |
35943-35-2 |
Triciribine is a potent Akt inhibitor with IC50 of 130 nM.... |
| Triciribine |
35943-35-2 |
Triciribine is a potent Akt inhibitor with IC50 of 130 nM.... |
| TWS119 |
601514-19-6 |
.... |
| TWS119 |
601514-19-6 |
.... |
| TWS119 |
601514-19-6 |
.... |
| VS-5584 |
1246560-33-7 |
VS-5584 is a selective dual PI3K/mTOR inhibitor that potently inhibits mTOR kinase PI3K isoforms.... |
| WAY-600 |
1062159-35-6 |
WAY-600 is a potent and ATP-competitive inhibitor of mTOR.... |
| WAY-600 |
1062159-35-6 |
WAY-600 is a potent and ATP-competitive inhibitor of mTOR.... |
| WAY-600 |
1062159-35-6 |
WAY-600 is a potent and ATP-competitive inhibitor of mTOR.... |
| WAY-600 |
1062159-35-6 |
WAY-600 is a potent and ATP-competitive inhibitor of mTOR.... |
| WYE-125132 |
1144068-46-1 |
WYE-125132 is a highly potent, ATP-competitive, and specific mTOR kinase inhibitor.... |
| WYE-354 |
1062169-56-5 |
WYE-354 is a potent and ATP-competitive inhibitor of mTOR.... |
| WYE-354 |
1062169-56-5 |
WYE-354 is a potent and ATP-competitive inhibitor of mTOR.... |
| WYE-354 |
1062169-56-5 |
WYE-354 is a potent and ATP-competitive inhibitor of mTOR.... |
| WYE-687 |
1062161-90-3 |
WYE-687 is a potent and ATP-competitive inhibitor of mTOR.... |
| WYE-687 |
1062161-90-3 |
WYE-687 is a potent and ATP-competitive inhibitor of mTOR.... |
| WYE-687 |
1062161-90-3 |
WYE-687 is a potent and ATP-competitive inhibitor of mTOR.... |
| WYE-687 |
1062161-90-3 |
WYE-687 is a potent and ATP-competitive inhibitor of mTOR.... |
| XL-765 (SAR-245409) |
1123889-87-1 |
XL765 is a potent and selective inhibitor of Class I PI3K isoforms and mTOR.... |
| XL-765 (SAR-245409) |
1123889-87-1 |
XL765 is a potent and selective inhibitor of Class I PI3K isoforms and mTOR.... |
| XL-765 (SAR-245409) |
1123889-87-1 |
XL765 is a potent and selective inhibitor of Class I PI3K isoforms and mTOR.... |
| XL-765 (SAR-245409) |
1123889-87-1 |
XL765 is a potent and selective inhibitor of Class I PI3K isoforms and mTOR.... |
| XL-765 (SAR-245409) |
1123889-87-1 |
XL765 is a potent and selective inhibitor of Class I PI3K isoforms and mTOR.... |
| XL-765 (SAR-245409) |
1123889-87-1 |
XL765 is a potent and selective inhibitor of Class I PI3K isoforms and mTOR.... |
| XL-765 (SAR-245409) |
1123889-87-1 |
XL765 is a potent and selective inhibitor of Class I PI3K isoforms and mTOR.... |
| XL147(SAR245408) |
956958-53-5 |
XL147 (SAR245408) is a PI3K inhibitor.... |
| XL147(SAR245408) |
956958-53-5 |
XL147 (SAR245408) is a PI3K inhibitor.... |
| XL147(SAR245408) |
956958-53-5 |
XL147 (SAR245408) is a PI3K inhibitor.... |
| XL147(SAR245408) |
956958-53-5 |
XL147 (SAR245408) is a PI3K inhibitor.... |
| XL147(SAR245408) |
956958-53-5 |
XL147 (SAR245408) is a PI3K inhibitor.... |
| XL147(SAR245408) |
956958-53-5 |
XL147 (SAR245408) is a PI3K inhibitor.... |
| XL147(SAR245408) |
956958-53-5 |
XL147 (SAR245408) is a PI3K inhibitor.... |
| XL765(SAR-245409) |
1349796-36-6 |
XL765 is a small molecule dual-targeted PI3K/mTOR inhibitor, which inhibits PI3Kα, PI3Kβ, PI3Kδ and PI3Kγwith IC50 values of 39, 113, 43 and 9 nM, respectively.... |
| XL765(SAR-245409) |
1349796-36-6 |
XL765 is a small molecule dual-targeted PI3K/mTOR inhibitor, which inhibits PI3Kα, PI3Kβ, PI3Kδ and PI3Kγwith IC50 values of 39, 113, 43 and 9 nM, respectively.... |
| XL765(SAR-245409) |
1349796-36-6 |
XL765 is a small molecule dual-targeted PI3K/mTOR inhibitor, which inhibits PI3Kα, PI3Kβ, PI3Kδ and PI3Kγwith IC50 values of 39, 113, 43 and 9 nM, respectively.... |
| XL765(SAR-245409) |
1349796-36-6 |
XL765 is a small molecule dual-targeted PI3K/mTOR inhibitor, which inhibits PI3Kα, PI3Kβ, PI3Kδ and PI3Kγwith IC50 values of 39, 113, 43 and 9 nM, respectively.... |
| ZSTK474 |
475110-96-4 |
ZSTK474 is an ATP-competitive pan-class I PI3K inhibitor.... |
| ZSTK474 |
475110-96-4 |
ZSTK474 is an ATP-competitive pan-class I PI3K inhibitor.... |
| ZSTK474 |
475110-96-4 |
ZSTK474 is an ATP-competitive pan-class I PI3K inhibitor.... |
| ZSTK474 |
475110-96-4 |
ZSTK474 is an ATP-competitive pan-class I PI3K inhibitor.... |
inhibitor-（PI3K/Akt/mTOR）